Literature DB >> 25458458

[Impact of a program designed to improve continuous renal replacement therapy stability].

M Page1, T Rimmelé2, J Prothet2, F Christin2, J Crozon2, C-E Ber2.   

Abstract

OBJECTIVES: During continuous renal replacement therapy (CRRT), circuit clotting increases nursing workload, cost of the therapy and blood loss. The aim of this study was to assess the impact of a program designed to improve CRRT stability on unexpected circuit clotting. STUDY
DESIGN: Retrospective and observational study. PATIENTS AND METHODS: In January 2011, several changes have been adopted regarding CRRT management. Regional citrate anticoagulation, continuous hemodialysis using super high-flux membranes and a specific training for intensive care unit nurses were implemented. CRRT sessions before (year 2009 and 2010, "Before group") and after (year 2011 and 2012, "After group") were analyzed. The primary endpoint was the incidence of unexpected CRRT session end.
RESULTS: During the study period, 401 sessions performed in 152 patients were analyzed. Sixty-three unexpected session's end (40%) occurred before and 43 (17%) after the implementation of the program (P<0.0001). Median filter life time was 33 (13-48) hours before and 55 (27-67) hours after (P<0.0001).
CONCLUSION: Our program designed to improve CRRT stability reduced filter losses by reducing unexpected circuit clotting.
Copyright © 2014 Société française d’anesthésie et de réanimation (Sfar). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Anticoagulation régionale au citrate; Circuit clotting; Hemodialysis; Hemofiltration; Hémodialyse; Hémofiltration; Regional citrate anticoagulation; Thrombose de filtre; Tinuous renal replacement therapy; Épuration extrarénale

Mesh:

Substances:

Year:  2014        PMID: 25458458     DOI: 10.1016/j.annfar.2014.10.008

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  3 in total

Review 1.  Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis.

Authors:  Matthew Brain; Elizabeth Winson; Owen Roodenburg; John McNeil
Journal:  BMC Nephrol       Date:  2017-02-20       Impact factor: 2.388

2.  Feasibility and efficacy of modified fixed citrate concentration protocol using only commercial preparations in critically ill patients: a prospective cohort study with a historical control group.

Authors:  Yan Shi; Han-Yu Qin; Jin-Min Peng; Xiao-Yun Hu; Bin Du
Journal:  BMC Anesthesiol       Date:  2021-03-30       Impact factor: 2.217

3.  Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit.

Authors:  Eloy F Ruiz; Victor M Ortiz-Soriano; Monica Talbott; Bryan A Klein; Melissa L Thompson Bastin; Kirby P Mayer; Emily B Price; Robert Dorfman; Brandi N Adams; Lisa Fryman; Javier A Neyra
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.